1,961
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Optimization of desolvation process for fabrication of lactoferrin nanoparticles using quality by design approach

, , , , &
Pages 1101-1114 | Received 07 Feb 2016, Accepted 13 Jun 2016, Published online: 15 Jul 2016

References

  • Alting AC, Hamer RJ, Kruif CG, Paques M, Visschers RW. 2003. Number of thiol groups rather than the size of the aggregates determine the hardness of cold set whey protein gels. Food Hydrocolloid. 17:469–479.
  • Azarmi S, Huang YH, Chen S, McQuarrie D, Abrams W, Roa WH, Finlay GG, Lobenberg MR. 2006. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells. J Pharm Pharm Sci. 9:124–132.
  • Berridge J. 2007. ICH Q8 & Q9 (+Q10) defined and undefined: gaps and opportunities. ISPE PQLI Washington Conference.
  • Bulgarelli E, Forni F, Bernabei MT. 1999. Casein/gelatin beads: I. Cross-linker solution composition effect on cross-linking degree. Int J Pharm. 190:175–182.
  • Chen Y, Willmott N, Anderson J, Florence AT. 1987. Comparison of albumin and casein microspheres as a carrier for doxorubicin. J Pharm Pharmacol. 39:978–985.
  • Ding D, Zhu Z, Liu Q, Wang J, Hu Y, Jiang X, Liu B. 2011. Cisplatin-loaded gelatinpoly (acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors. Eur J Pharm Biopharm. 79:142–149.
  • Duarte DC, Nicolau A, Teixeira JA, Rodrigues LR. 2011. The effect of bovine milk lactoferrin on human breast cancer cell lines. J Dairy Sci. 94:66–76.
  • Eissa AS. 2012. Newtonian viscosity behavior of dilute solutions of polymerized whey proteins. Would viscosity measurements reveal more detailed molecular properties. Food Hydrocolloid. 30:200–205.
  • Elzoghby AO, Abo El-Fotoh WS, Elgindy NA. 2011. Casein-based formulations as promising controlled release drug delivery systems. J Control Release. 153:206–216.
  • Elzoghby AO, Samy WM, Elgindy NA. 2012a. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 167:168–182.
  • Elzoghby AO, Samy WM, Elgindy NA. 2012b. Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release. 161:38–49.
  • Erol Y, Borchert HH. 2005. Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. Eur J Pharm Biopharm. 60:91–98.
  • Fahmy R, Kona R, Dandu R, Xie W, Claycamp G, Hoag SW. 2012. Quality by design I: application of failure mode effect analysis (FMEA) and Plackett-Burman design of experiments in the identification of “main factors” in the formulation and process design space for roller-compacted ciprofloxacin hydrochloride immediate-release tablets. AAPS PharmSciTech. 13:1243–1254.
  • Forrest SA, Yada RY, Rousseau D. 2005. Interactions of vitamin D3 with bovine beta-lactoglobulin A and beta-casein. J Agric Food Chem. 53:8003–8009.
  • Gubbins RH, O’Driscoll CM, Corrigan OI. 2003. The effects of casein on diclofenac release from hydroxypropylmethylcellulose (HPMC) compacts. Int J Pharm. 260:69–76.
  • Gunasekaran S, Ko S, Xiao L. 2007. Use of whey proteins for encapsulation and controlled delivery applications. J Food Eng. 83:31–40.
  • Hemar YM, Gerbeaud CM, Augustin MA. 2011. Investigation into the interaction between resveratrol and whey proteins using fluorescence spectroscopy. Int J Food Sci Technol. 46:2137–2144.
  • Knepp WA, Jayakrishnan A, Quigg JM, Sitren HS, Bagnall JJ, Goldberg EP. 1993. Synthesis, properties, and intratumoral evaluation of mitoxantrone-loaded casein microspheres in Lewis lung carcinoma. J Pharm Pharmacol. 45:887–891.
  • Kudarha RR, Dhas NL, Pandey AP, Belgamwar VS, Ige PP. 2015. Box–Behnken study design for optimization of bicalutamide-loaded nanostructured lipid carrier: stability assessment. Pharm Dev Technol. 20:608–618.
  • Kytariolos J, Charkoftaki G, Smith JR, Voyiatzis G, Chrissanthopoulos A, Yannopoulos SN, Fatouros DG, Macheras P. 2013. Stability and physicochemical characterization of novel milk-based oral formulations. Int J Pharm. 444:128–138.
  • Langer K, Balthasar S, Vogel V, Dinauer N, Briesen HV, Schubert D. 2003. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 257:169–180.
  • Leila B, Madadlou A, Yarmand M, Mousavi ME. 2013. Nanoencapsulation of date palm pit extract in whey protein particles generated via desolvation method. Food Res Int. 51:866–871.
  • Leo E, Vandelli MA, Cameroni R, Forni F. 1997. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. Int J Pharm. 155:75–82.
  • Li D, Sakashita S, Morishita Y, Kano J, Shiba A, Sato T, Noguchi M. 2011. Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line. Anticancer Res. 31:529–534.
  • Livney YD. 2010. Milk proteins as vehicles for bioactives. Curr Opin Colloid. 15:73–83.
  • Mehravar R, Jahanshahi M, Saghatoleslami N. 2009. Production of biological nanoparticles from α-lactalbumin for drug delivery and food science application. Afr J Biotechnol. 8:6822–6827.
  • Millar FC, Corrigan OI. 1993. Dissolution mechanism of ibuprofen-casein compacts. Int J Pharm. 92:97–104.
  • Mohan V, Jurat-Fuentes JL, Harte F. 2013. Binding of vitamin A by casein micelles in commercial skim milk. J Dairy Sci. 96:790–798.
  • Nicolai T, Britten M, Schmitt C. 2011. β-Lactoglobulin and WPI aggregates: formation, structure and applications. Food Hydrocolloid. 25:1945–1962.
  • Pandey AP, Karande KP, Sonawane RO, Deshmukh PK. 2014a. Applying quality by design (QbD) concept for fabrication of chitosan coated nanoliposomes. J Liposome Res. 1:37–52.
  • Pandey AP, Singh SS, Patil GB, Patil PO, Bhavsar CJ, Deshmukh PK. 2014b. Sonication-assisted drug encapsulation in layer-by-layer self-assembled gelatin-poly (styrenesulfonate) polyelectrolyte nanocapsules: process optimization. Artif Cells Nanomed Biotechnol. 43:413–424.
  • Park YG, Jeong JK, Lee JH, Lee YJ, Seol JW, Kim SJ, et al. 2013. Lactoferrin protects against prion protein-induced cell death in neuronal cells by preventing mitochondrial dysfunction. Int J Mol Med. 31:325–330.
  • Puyol P, Perez MD, Ena JM, Calvo M. 1991. Interaction of β-lactoglobulin and other bovine and human whey proteins with retinol and fatty acids. Agric Biol Chem. 55:2515–2520.
  • Qi PX, Onwulata CI. 2011. Physical properties, molecular structures, and protein quality of texturized whey protein isolate: effect of extrusion temperature. J Agr Food Chem. 59:4668–4675.
  • Rathore AS, Bhambure R, Ghare V. 2010. Process analytical technology (PAT) for biopharmaceutical products. Anal Bioanal Chem. 398:137–154.
  • Robert AL, Lee SL, Lee LM, Raw A, Yu LX. 2008. Quality by design: concepts for ANDAs. AAPS J. 10:268–276.
  • Singh HD, Wang G, Uludag H, Unsworth LD. 2010. Poly-L-lysine-coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. Acta Biomater. 6:4277–4284.
  • Song F, Zhang LM, Yang C, Yan L. 2009. Genipin-crosslinked casein hydrogels for controlled drug delivery. Int J Pharm. 373:41–47.
  • Vivek SJ, Abhijeet PP, Pravin RP, Prashant KD. 2015. Magnetically responsive siliceous frustules for efficient chemotherapy. Mater Sci Eng C Mater Biol Appl. 50:107–116.
  • Zhen X, Wang X, Xie C, Wu W, Jiang X. 2013. Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. Biomaterials. 34:1372–1382.
  • Zimet P, Rosenberg D, Livney YD. 2013. Re-assembled casein micelles and casein nanoparticles as nano-vehicles for ω-3 polyunsaturated fatty acids. Food Hydrocolloid. 25:1270–1276.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.